Efficacy of Implantable Defibrillator Therapy After a Myocardial Infarction
- Conditions
- Myocardial InfarctionSudden Death
- Registration Number
- NCT00673842
- Lead Sponsor
- University of Calgary
- Brief Summary
This study will assess whether an implantable defibrillator will increase the likelihood of survival in patients who have had a heart attack, have abnormal test results from a 24 hour heart monitor, and who have low normal heart function.
- Detailed Description
The REFINE ICD trial will assess whether prophylactic ICD therapy, guided by non-invasive risk assessment tools, reduces mortality in MI survivors with better-preserved LV function.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 700
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Mortality Minimum of 18 months of follow-up (average follow-up of 5 years).
- Secondary Outcome Measures
Name Time Method Appropriate ICD therapies Average follow-up 5 years. Arrhythmic syncope Average follow-up 5 years. Arrhythmic death Average follow-up 5 years. Inappropriate ICD therapies Five years (average) Quality of life Average follow-up 5 years. Cardiac death Average follow-up 5 years.
Trial Locations
- Locations (78)
Heart Center Research LLC
🇺🇸Huntsville, Alabama, United States
Colorado Heart and Vascular
🇺🇸Lakewood, Colorado, United States
James A Haley Veterans' Center
🇺🇸Tampa, Florida, United States
The Heart Group/Deaconess
🇺🇸Evansville, Indiana, United States
Iowa Heart Center
🇺🇸West Des Moines, Iowa, United States
Delmarva Heart Foundation
🇺🇸Salisbury, Maryland, United States
Beth Israel Deaconess
🇺🇸Boston, Massachusetts, United States
Washington University Medical School
🇺🇸Saint Louis, Michigan, United States
St. John Providence Hospital
🇺🇸Southfield, Michigan, United States
Lester E Cox Medical Center
🇺🇸Springfield, Missouri, United States
Scroll for more (68 remaining)Heart Center Research LLC🇺🇸Huntsville, Alabama, United States